July 27, 2016
Recommended Topic Related To:

VisionBlue

"LONDON, UK ” The European Commission (EC) has followed the recommendation last year from its Committee for Medicinal Products for Human Use (CHMP) for an additional indication for the oral platelet inhibitor ticagrelor (Brilique, AstraZe"...

A A A

VisionBlue

PATIENT INFORMATION

No information provided. Please refer to the PRECAUTIONS section.

Last reviewed on RxList: 4/8/2009
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.